The Weekly Brief: Edition 3

The week in women's health research, explained plainly: phone coaching and diabetes in pregnancy, closer watching for slow growing babies, cannabis and tobacco in pregnancy, testosterone in menopause, and the pill and blood clots.

Share
The Weekly Brief: Edition 3

This newsletter is for education only and is not medical advice. Kelette Health does not provide medical care and does not create a doctor-patient relationship. Talk to your own clinician about your situation. If you have a medical emergency, call your local emergency number.

Welcome to the third edition of the Kelette Health Weekly Brief. Every week we read the major medical journals and translate the findings that matter for women's health into plain language. Here is this week in five short reads.

Today is a big day at Kelette Health: our complete Hysterectomy guide series launches, all eight guides, from Hysterectomy, Explained Plainly to Life After Hysterectomy, including Complications and Warning Signs, which is fully public as a safety guide. Preview each guide free, and join free to read it in full.

Tomorrow's new guide: Vaccines in Pregnancy: What Is Recommended, and When. The four vaccines recommended in pregnancy, when each one is given, and where ACOG and the CDC now differ, in plain language.

Tomorrow's new guide: Vaginal and Urinary Changes After Menopause (GSM): What Helps, What's Safe. Dryness, pain with sex, urgency, and infections that keep coming back are not something you have to just accept. What helps, what is safe, and when to get checked, in plain language.

Coaching on your phone in pregnancy: fewer cases of gestational diabetes

If you are at higher risk of gestational diabetes, could regular coaching on your phone help? A trial across Australia, Ireland, Spain, and the UK gave 865 pregnant women either personalised smartphone coaching alongside usual care, or usual care alone, from early pregnancy through the baby's first year. Coaching did not change mothers' weight a year after birth, which the researchers measured first. But fewer women who received coaching developed gestational diabetes: 14% compared with 20%. Support that fits into daily life may prevent diabetes in pregnancy even when the scale does not move, and that is worth asking your care team about if your risk is higher.

When a growing baby is watched closely, outcomes even out

Stillbirth is rare, and it is not shared equally: in the UK, babies of Asian and Black mothers are stillborn more often than babies of White mothers. A large UK study of about 179,000 pregnancies looked for where that gap comes from, and one finding stands out with hope in it. When a baby who was growing slowly was spotted before birth and the mother received closer surveillance, the gap between ethnic groups disappeared. When slow growth was missed, the gap remained. No parent causes this difference; it is about detection and systems. It is also why growth checks and scans in later pregnancy matter, and why you should always mention reduced baby movements promptly, whatever your background.

Cannabis and tobacco in pregnancy: what a study of 18 million pregnancies found

A new analysis combined 79 studies covering about 18 million pregnancies to ask what cannabis use in pregnancy means for babies. Babies exposed to cannabis were more likely to be born small, to have a low birth weight, and to need intensive care, and part of that risk appears to come from tobacco, which often travels with cannabis. When researchers compared groups with similar tobacco use, the growth effects remained: exposed babies were still more likely to be small. The evidence is not perfect, and the researchers rate its certainty as very low, but the direction is consistent. The safest course in pregnancy is to avoid both cannabis and tobacco, and if quitting either feels hard, that is a reason to ask your care team for support, never a reason for shame.

You may see testosterone promoted for energy, mood, brain fog, and low desire after menopause. A study of more than 10,000 women who started testosterone found that prescribing has risen steeply since 2022, yet only 17% had the one condition it is evidence based for: distressing low sexual desire after menopause. Blood levels were checked in only about 1 in 10 women after starting, and among those checked, more than a third had levels above the usual female range. Testosterone can be a reasonable, carefully monitored option for the right person; it is not a general tonic, and long term safety data are limited. If you use it, or are offered it, ask what it is for, what level is being aimed for, and when it will be checked.

The pill and blood clots: the estrogen dose matters

Combined birth control pills slightly raise the risk of a blood clot, and a large Japanese study has now measured how much the dose matters. Using health records and a design that mimics a clinical trial, researchers found that pill users had about twice the rate of thrombosis (a blood clot) of non users over a year, and that pills with a higher estrogen dose carried a higher risk than lower dose pills. Twice a very small risk is still a small risk for most healthy young women, and pregnancy itself carries a higher clot risk than the pill does. Your personal picture matters most: smoking, migraine with aura, high blood pressure, a past clot, or a strong family history all change the balance. If you take the pill, it is worth one conversation with your clinician about whether your dose and your risk factors still fit together, and never stop suddenly without a backup plan.

Sources

O'Reilly SL et al. Personalised mobile health coaching from early pregnancy to 12-months postpartum for females at risk of gestational diabetes (Bump2Baby and Me): a multicentre, randomised controlled trial. The Lancet Digital Health, published November 12, 2026. https://pubmed.ncbi.nlm.nih.gov/43020746/

Winsloe C, Elhindi J, Vieira MC et al. Ethnic disparities in stillbirth and the effect of maternal factors, antenatal ultrasound, and antenatally suspected small-for-gestational-age as a marker of enhanced antenatal surveillance in the UK (DESiGN): a secondary cohort analysis nested within a randomised trial. The Lancet Obstetrics, Gynaecology, and Women's Health, published online November 11, 2026. https://www.thelancet.com/journals/lanogw/article/PIIS3050-5038(26)00288-8/fulltext

Sainz K et al. Prenatal cannabis exposure and adverse neonatal outcomes: a systematic review and meta-analysis with meta-regression on tobacco co-use. BMJ Paediatrics Open, published online November 13, 2026. https://marchandinstitute.org/bmj-paediatrics-open-prenatal-cannabis-tobacco-meta-analysis/

Jorgensen SCJ, McClure DL. Testosterone prescribing and persistence among adult females: a new-user cohort study. The Journal of Clinical Endocrinology & Metabolism, published November 10, 2026. https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgag444/9027055

Takeshita S, Nishioka Y, Morita E et al. Risk of thrombosis associated with oral contraceptive pills use in Japan: a target trial emulation study. Scientific Reports, published November 12, 2026. https://www.nature.com/articles/s41598-026-74972-9

Get the Brief on WhatsApp: Follow the Kelette Health WhatsApp channel and the Weekly Brief arrives where you already chat, every Thursday. Tap the link, then tap Follow at the top of the channel: https://whatsapp.com/channel/0029VbDXzznBVJl4ye9xCM1X

Chukwuma M Okoroji, MD, FAAFP, FACOG

Kelette Health

New here?: Every Kelette Health guide now opens with a free preview. Join free to read each guide in full, and to receive the Weekly Brief and a new guide every Friday. Joining is free through January 2027.

One favour before you go:

If this Brief helped you, forward it to one woman who would want it. Every guide on Kelette Health is free, and joining takes less than a minute.

Thank you for helping this reach the women who need it.

Until next week,

Chukwuma M Okoroji, MD, FAAFP, FACOG

Kelette Health

This newsletter is for education only and is not medical advice. Kelette Health does not provide medical care and does not create a doctor-patient relationship. Talk to your own clinician about your situation. If you have a medical emergency, call your local emergency number.

This guide is for education only and is not medical advice. Kelette Health does not provide medical care and does not create a doctor–patient relationship. Talk to your own clinician about your situation. If you have a medical emergency, call your local emergency number.
Follow Kelette Health on WhatsApp